Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus.
Related posts
-
A time for change: Meet the class of new mayors in DuPage, Kane suburbs
Mayoral challengers across DuPage and Kane counties had a strong showing in last week’s election. Here’s... -
Firefighter suffers minor injuries battling Bartlett blaze
A firefighter suffered smoke inhalation, but no other injuries were reported, after fire broke out Saturday... -
Illinois governor moves to slash cover crop funds despite rising demand
Six years ago, Illinois became the second state in the nation to offer subsidies to farmers...